fashion -WSS

fashion

author：fashion 2025-09-30 22:55:05 - browse：9

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Tuskegee Airman Raymond Cassagnol dies at 102

hotspot

WSS

How to convince healthy people to buy insurance

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Medicare proceeds with plan to claw back hospital funds

ADA: All diabetes patients should be screened for liver condition

Key Senate panel to consider PBM, drug pricing reform package

How neuroscience research could help beat back brain cancer

hotspot

fashion

explore

Walensky prepares to leave CDC — and Congress — behind

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Supreme Court strikes down use of affirmative action

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Hollywood unions extend contract negotiations for actors

Gene therapy’s promise and the high cost of hope

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Anesthesiologist group: stop taking Ozempic before surgery

Inari Medical to buy amputation prevention company LimFlow

explore

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Life sciences investors close nearly $6 billion in new funds

The health care issue Democrats can’t solve: hospital reform

Why do we get seasonal allergies?

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

entertainment

hotspot

leisure time

hotspot